富士製薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/08/14 | 1,287 | 1,301 | 1,277 | 1,292 | +11 | +0.9% | 9,400 |
2019/08/13 | 1,304 | 1,304 | 1,264 | 1,281 | -27 | -2.1% | 17,900 |
2019/08/09 | 1,346 | 1,350 | 1,304 | 1,308 | -43 | -3.2% | 33,500 |
2019/08/08 | 1,340 | 1,368 | 1,315 | 1,351 | +25 | +1.9% | 24,100 |
2019/08/07 | 1,359 | 1,380 | 1,326 | 1,326 | -25 | -1.9% | 21,800 |
2019/08/06 | 1,310 | 1,353 | 1,301 | 1,351 | -19 | -1.4% | 18,000 |
2019/08/05 | 1,388 | 1,388 | 1,342 | 1,370 | -40 | -2.8% | 30,300 |
2019/08/02 | 1,434 | 1,434 | 1,403 | 1,410 | -35 | -2.4% | 23,900 |
2019/08/01 | 1,451 | 1,456 | 1,434 | 1,445 | -18 | -1.2% | 18,600 |
2019/07/31 | 1,461 | 1,477 | 1,450 | 1,463 | -8 | -0.5% | 13,300 |
2019/07/30 | 1,436 | 1,473 | 1,436 | 1,471 | +30 | +2.1% | 17,000 |
2019/07/29 | 1,439 | 1,442 | 1,427 | 1,441 | +7 | +0.5% | 15,400 |
2019/07/26 | 1,422 | 1,439 | 1,410 | 1,434 | +12 | +0.8% | 13,400 |
2019/07/25 | 1,406 | 1,425 | 1,400 | 1,422 | +7 | +0.5% | 7,500 |
2019/07/24 | 1,431 | 1,436 | 1,407 | 1,415 | -16 | -1.1% | 28,800 |
2019/07/23 | 1,425 | 1,438 | 1,424 | 1,431 | +6 | +0.4% | 10,800 |
2019/07/22 | 1,449 | 1,449 | 1,418 | 1,425 | -16 | -1.1% | 12,400 |
2019/07/19 | 1,399 | 1,449 | 1,398 | 1,441 | +32 | +2.3% | 25,300 |
2019/07/18 | 1,444 | 1,444 | 1,388 | 1,409 | -38 | -2.6% | 32,200 |
2019/07/17 | 1,451 | 1,462 | 1,439 | 1,447 | -16 | -1.1% | 17,900 |
2019/07/16 | 1,470 | 1,471 | 1,450 | 1,463 | -13 | -0.9% | 14,400 |
2019/07/12 | 1,487 | 1,488 | 1,467 | 1,476 | -9 | -0.6% | 11,000 |
2019/07/11 | 1,469 | 1,495 | 1,459 | 1,485 | +30 | +2.1% | 16,600 |
2019/07/10 | 1,435 | 1,465 | 1,435 | 1,455 | -10 | -0.7% | 19,800 |
2019/07/09 | 1,468 | 1,492 | 1,460 | 1,465 | -2 | -0.1% | 14,500 |
2019/07/08 | 1,500 | 1,508 | 1,461 | 1,467 | -33 | -2.2% | 21,800 |
2019/07/05 | 1,499 | 1,506 | 1,465 | 1,500 | -10 | -0.7% | 34,900 |
2019/07/04 | 1,481 | 1,528 | 1,470 | 1,510 | +32 | +2.2% | 36,500 |
2019/07/03 | 1,445 | 1,486 | 1,430 | 1,478 | +28 | +1.9% | 28,100 |
2019/07/02 | 1,452 | 1,468 | 1,416 | 1,450 | -2 | -0.1% | 24,300 |
2019/07/01 | 1,423 | 1,457 | 1,420 | 1,452 | +60 | +4.3% | 33,800 |
2019/06/28 | 1,396 | 1,413 | 1,390 | 1,392 | -4 | -0.3% | 13,600 |
2019/06/27 | 1,399 | 1,408 | 1,385 | 1,396 | -4 | -0.3% | 13,600 |
2019/06/26 | 1,409 | 1,418 | 1,400 | 1,400 | -6 | -0.4% | 14,300 |
2019/06/25 | 1,413 | 1,433 | 1,404 | 1,406 | -7 | -0.5% | 13,200 |
2019/06/24 | 1,440 | 1,440 | 1,409 | 1,413 | -35 | -2.4% | 17,700 |
2019/06/21 | 1,373 | 1,471 | 1,364 | 1,448 | +78 | +5.7% | 65,900 |
2019/06/20 | 1,386 | 1,388 | 1,366 | 1,370 | -16 | -1.2% | 11,700 |
2019/06/19 | 1,378 | 1,396 | 1,372 | 1,386 | +23 | +1.7% | 14,800 |
2019/06/18 | 1,413 | 1,413 | 1,363 | 1,363 | -39 | -2.8% | 19,600 |
2019/06/17 | 1,402 | 1,411 | 1,393 | 1,402 | -2 | -0.1% | 15,600 |
2019/06/14 | 1,419 | 1,430 | 1,404 | 1,404 | -18 | -1.3% | 21,800 |
2019/06/13 | 1,429 | 1,430 | 1,406 | 1,422 | -11 | -0.8% | 17,400 |
2019/06/12 | 1,441 | 1,449 | 1,431 | 1,433 | -16 | -1.1% | 11,200 |
2019/06/11 | 1,430 | 1,452 | 1,410 | 1,449 | +19 | +1.3% | 18,300 |
2019/06/10 | 1,432 | 1,439 | 1,417 | 1,430 | +10 | +0.7% | 9,000 |
2019/06/07 | 1,420 | 1,424 | 1,409 | 1,420 | ±0 | ±0% | 13,600 |
2019/06/06 | 1,436 | 1,443 | 1,420 | 1,420 | -31 | -2.1% | 14,400 |
2019/06/05 | 1,430 | 1,462 | 1,430 | 1,451 | +30 | +2.1% | 17,900 |
2019/06/04 | 1,406 | 1,427 | 1,394 | 1,421 | +24 | +1.7% | 20,700 |
1401~
1450
件表示中 / 6949件
類似銘柄と比較する
現在ご覧いただいている「富士製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
富士製薬 | 130,200円 | +15.7% | +5.3% | 3.49% | 9.41倍 | 0.70倍 |
|
女性医療、急性期医療の2領域に強い後発薬メーカー。注射剤が主体。新薬・バイオ後続品も |
タウンズ | 50,800円 | +4.6% | +6.1% | 5.51% | 8.64倍 | 3.19倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
生化学 | 72,200円 | +9.2% | +39.0% | 4.16% | 23.88倍 | 0.52倍 |
|
複合糖質で独自性。開発は関節疾患関連に特化。2種のヒアルロン酸製剤は科研と参天が販売 |
ダイト | 207,000円 | +4.5% | -33.7% | 3.38% | 20.70倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 30,300円 | +150.0% | - | 0.00% | - | 14.90倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム